Resource Library

This is a discussion paper on financial options to assist in the battle against online IP Piracy in the United Kingdom.

This article describes a decision by the Singapore High Court (Towa Corporation v ASM Technology Singapore Pte Ltd & Anor [2014] SGHCR 16.

This is a sample limited copyright license agreement.

This is a report on EU e-marketing requirements.

Article 20 of the new Loi de Programmation Militaire has been described as the “French Patriot Act.” It gives the French administration new surveillance powers, allowing it to request content, data and metadata, including geo-location data. This article provides an overview of the key provisions of this new law.

This policy template helps employers frame that sales and marketing activities comply with all applicable Federal and State laws and regulations, including, but not limited to, Federal and State physician self-referral laws.

This document’s purpose is to illustrate possible metrics to be considered when measuring an Intellectual Property Portfolio.

Beginning on 1 January 2014, French pharmacists are now legally permitted to substitute a biosimilar for the prescribed (reference) biological medicine as long as the prescribing physician has not marked the prescription as “non-substitutable.” According to the new law, substitution is allowed only when initiating a course of treatment, and if the biosimilar belongs to the same group as the prescribed product, known as a “similar biologic group.” The criteria for inclusion in a “similar biologic group” have yet to be defined by the French healthcare authority (ANSM).

This resource provides an overview of patent regulations in Switzerland, with a focus on enforcement proceedings, licensing, and ownership.

This article outlines what trade secret protection is, why you might choose it instead of a patent, and how to implement it.